Ofatumumab is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Ofatumumab becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Information about GlobalPharmacyMeds.to
List of countries where we can ship Ofatumumab:
Latest news releases on Ofatumumab:
Physician reviewed ofatumumab patient information - includes ofatumumab description, dosage and directions.
Ofatumumab is a human monoclonal antibody which targets an epitope in the CD20 molecule encompassing parts of the small and large extracellular loops.
Duvelisib Bests Ofatumumab in Relapsed and Refractory CLL/SLL - Chronic Leukemias, From the Blood Journals, News, Written in Blood - ASH Clinical News
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis (ASCLEPIOS I)
Drug status: Ofatumumab: (PBS authority) ofatumumab must be given in combination with chlorambucil; Chlorambucil is available on the PBS general schedule
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis. (ASCLEPIOS II)
This guidance has been withdrawn because Novartis has discontinued ofatumumab (Arzerra)
Produkter. Genmab har udviklet flere lægemidler: Antistoffet ofatumumab bliver markedsført under navnet Arzerra og er godkendt til behandlinger af kronisk lymfatisk ...
PHILADELPHIA — Further analysis of data from the phase 2 study with the anti–B cell antibody ofatumumab (Arzerra, Genmab) has suggested that an optimal dose can ...
Genmab has two products on the market, DARZALEX ® (daratumumab) and Arzerra ® (ofatumumab), and is developing a pipeline of antibody therapeutics for the treatment ...